A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous Garadacimab (CSL312) in Healthy Subjects - McKenzie, Andrew; Roberts, Anthony; Malandkar, Sourabh; Feuersenger, Henrike; Panousis, Con; Pawaskar, Dipti (Journal of allergy and clinical immunology, 2021)
Keywords: Double-blind studies; Intravenous administration; Pharmacokinetics; Placebos